Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Jun 2;300(6737):1409–1410. doi: 10.1136/bmj.300.6737.1409

The natural course of myasthenia gravis.

V Fonseca 1, C W Havard 1
PMCID: PMC1663145  PMID: 2198968

Full text

PDF
1409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckingham J. M., Howard F. M., Jr, Bernatz P. E., Payne W. S., Harrison E. G., Jr, O'Brien P. C., Weiland L. H. The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg. 1976 Oct;184(4):453–458. doi: 10.1097/00000658-197610000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fonseca V., Havard C. W. Long term treatment of myasthenia gravis with azathioprine. Postgrad Med J. 1990 Feb;66(772):102–105. doi: 10.1136/pgmj.66.772.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Grob D., Brunner N. G., Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci. 1981;377:652–669. doi: 10.1111/j.1749-6632.1981.tb33764.x. [DOI] [PubMed] [Google Scholar]
  4. Havard C. W., Fonseca V. New treatment approaches to myasthenia gravis. Drugs. 1990 Jan;39(1):66–73. doi: 10.2165/00003495-199039010-00006. [DOI] [PubMed] [Google Scholar]
  5. MILLER J. F. Immunological function of the thymus. Lancet. 1961 Sep 30;2(7205):748–749. doi: 10.1016/s0140-6736(61)90693-6. [DOI] [PubMed] [Google Scholar]
  6. Mertens H. G., Hertel G., Reuther P., Ricker K. Effect of immunosuppressive drugs (azathioprine). Ann N Y Acad Sci. 1981;377:691–699. doi: 10.1111/j.1749-6632.1981.tb33767.x. [DOI] [PubMed] [Google Scholar]
  7. Oosterhuis H. J. Long-term effects of treatment in 374 patients with myasthenia gravis. Monogr Allergy. 1988;25:75–85. [PubMed] [Google Scholar]
  8. Oosterhuis H. J. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1121–1127. doi: 10.1136/jnnp.52.10.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pascuzzi R. M., Coslett H. B., Johns T. R. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol. 1984 Mar;15(3):291–298. doi: 10.1002/ana.410150316. [DOI] [PubMed] [Google Scholar]
  10. Rowland L. P. Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644–659. doi: 10.1136/jnnp.43.7.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SIMPSON J. A. An evaluation of thymectomy in myasthenia gravis. Brain. 1958 Mar;81(1):112–144. doi: 10.1093/brain/81.1.112. [DOI] [PubMed] [Google Scholar]
  12. Simpson J. A., Thomaides T. Treatment of myasthenia gravis: an audit. Q J Med. 1987 Aug;64(244):693–704. [PubMed] [Google Scholar]
  13. Tindall R. S., Rollins J. A., Phillips J. T., Greenlee R. G., Wells L., Belendiuk G. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med. 1987 Mar 19;316(12):719–724. doi: 10.1056/NEJM198703193161205. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES